JESSICA P HWANG to Hepacivirus
This is a "connection" page, showing publications JESSICA P HWANG has written about Hepacivirus.
Connection Strength
1.348
-
Strategies to identify hepatitis C virus infection in patients receiving anticancer therapy: a cross-sectional study. Support Care Cancer. 2021 Jan; 29(1):97-105.
Score: 0.565
-
Hepatitis C virus screening in patients with cancer receiving chemotherapy. J Oncol Pract. 2014 May; 10(3):e167-74.
Score: 0.370
-
Antiviral therapy use and related outcomes in patients with cancer and viral infections: results from SWOG S1204. Support Care Cancer. 2022 Dec 31; 31(1):93.
Score: 0.170
-
Oncologic Implications of Chronic Hepatitis C Virus Infection. J Oncol Pract. 2019 12; 15(12):629-637.
Score: 0.138
-
Implementation of Universal Hepatitis C Virus Screening in a Tertiary Cancer Center. J Natl Compr Canc Netw. 2024 05 10; 22(2 D).
Score: 0.047
-
Hepatitis B virus reactivation in cancer patients receiving direct-acting antivirals for hepatitis C virus infection. J Viral Hepat. 2021 05; 28(5):844-848.
Score: 0.037
-
Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients. J Hepatol. 2012 Dec; 57(6):1177-85.
Score: 0.021